** Shares of IDT Australia RIC rise 8.9% to A$0.098; marks biggest intraday percentage gain since January 28

** The pharma manufacturer secures manufacturing contract with Nacuity Pharmaceuticals Pty for NPI-001, an investigational treatment for retinitis pigmentosa

** Five-year contract with initial A$3.2 million ($1.91 million) work expected to complete by FY2026, adds co

** Stock down 18.2% this year, as of last close

($1 = 1.6753 Australian dollars)

(Reporting by Sherin Sunny in Bengaluru)

((Sherin.Sunny@thomsonreuters.com))